Advertisement
Screener

Synergy CHC Corp. (SNYR) Cash and Cash Equivalents, Period Increase (Decrease)

Synergy CHC Corp. Cash and Cash Equivalents, Period Increase (Decrease)

Synergy CHC Corp. (SNYR) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$269.43 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-15.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-05-15

  • Synergy CHC Corp. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$269.43K.
  • Synergy CHC Corp. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$3.45M.
  • Synergy CHC Corp. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $4.51M, a 272.03% increase year-over-year.
  • Synergy CHC Corp. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$820.76K.
  • Synergy CHC Corp. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$562.03K.
  • Synergy CHC Corp. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$1.12M, a 130.85% decline from fiscal 2015.
  • Synergy CHC Corp. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $3.64M.
  • Synergy CHC Corp. cash and cash equivalents, period increase (decrease) for fiscal 2014 was -$2.89K.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 5 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 monthCash and Cash Equivalents, Period Increase (Decrease) 37 month
2018-03-31-$269.43K
10-Q · filed 2018-05-15
-$3.72M
derived: sum of 2 quarters · filed 2018-05-15
$791.95K
derived: sum of 3 quarters · filed 2018-05-15
-$28.81K
derived: sum of 4 quarters · filed 2018-05-15
2017-12-31-$3.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
$1.06M
derived: sum of 2 quarters · filed 2018-04-02
$240.63K
derived: sum of 3 quarters · filed 2018-04-02
-$562.03K
10-K · filed 2018-04-02
2017-09-30$4.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13
$3.69M
derived: sum of 2 quarters · filed 2017-11-13
$2.89M
10-Q · filed 2017-11-13
$1.19M
derived: sum of 4 quarters · filed 2018-05-15
2017-06-30-$820.76K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
-$1.62M
10-Q · filed 2017-08-14
-$3.33M
derived: sum of 3 quarters · filed 2018-05-15
-$2.11M
derived: sum of 4 quarters · filed 2018-05-15
2017-03-31-$802.65K
10-Q · filed 2018-05-15
-$2.51M
derived: sum of 2 quarters · filed 2018-05-15
-$1.29M
derived: sum of 3 quarters · filed 2018-05-15
-$2.05M
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31-$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
-$488.97K
derived: sum of 2 quarters · filed 2018-04-02
-$1.25M
derived: sum of 3 quarters · filed 2018-04-02
-$1.12M
10-K · filed 2018-04-02
2016-09-30$1.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13
$457.06K
derived: sum of 2 quarters · filed 2017-11-13
$579.25K
10-Q · filed 2017-11-13
$3.40M
derived: sum of 4 quarters · filed 2017-11-13
2016-06-30-$756.47K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
-$634.28K
10-Q · filed 2017-08-14
$2.18M
derived: sum of 3 quarters · filed 2017-08-14
$2.37M
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$122.19K
10-Q · filed 2017-05-01
$2.94M
derived: sum of 2 quarters · filed 2017-05-01
$3.13M
derived: sum of 3 quarters · filed 2017-05-01
$2.05M
derived: sum of 4 quarters · filed 2017-05-01
2015-12-31$2.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24
$3.00M
derived: sum of 2 quarters · filed 2017-03-24
$1.92M
derived: sum of 3 quarters · filed 2017-03-24
$3.64M
10-K · filed 2017-03-24
2015-09-30$187.71K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26
-$891.10K
derived: sum of 2 quarters · filed 2016-10-26
$824.61K
10-Q · filed 2016-10-26
$813.01K
derived: sum of 4 quarters · filed 2016-10-26
2015-06-30-$1.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
$636.90K
10-Q · filed 2016-08-05
$625.30K
derived: sum of 3 quarters · filed 2016-08-05
$450.60K
derived: sum of 4 quarters · filed 2016-08-05
2015-03-31$1.72M
10-Q · filed 2016-04-25
$1.70M
derived: sum of 2 quarters · filed 2016-04-25
$1.53M
derived: sum of 3 quarters · filed 2016-04-25
$1.71M
derived: sum of 4 quarters · filed 2016-04-25
2014-12-31-$11.60K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
-$186.30K
derived: sum of 2 quarters · filed 2016-03-30
-$2.32K
derived: sum of 3 quarters · filed 2016-03-30
-$2.89K
10-K · filed 2016-03-30
2014-09-30-$174.70K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16
$9.28K
derived: sum of 2 quarters · filed 2015-11-16
$8.71K
10-Q · filed 2015-11-16
2014-06-30$183.98K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
$183.41K
10-Q · filed 2015-08-13
2014-03-31-$570.00
10-Q · filed 2015-05-15
2014-01-31-$31.25K
10-Q/A · filed 2014-03-10
$2.66K
10-Q/A · filed 2014-03-10
2013-12-31-$30.68K
10-K · filed 2015-03-31
2013-09-30-$11.81K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31
$27.92K
derived: sum of 2 quarters · filed 2014-10-31
$27.38K
10-Q · filed 2014-10-31
2013-07-31$29.91K
10-K · filed 2015-03-31
2013-06-30$39.74K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-28
$39.20K
10-Q · filed 2014-08-28
2013-03-31-$538.00
10-Q · filed 2014-08-28
2013-01-31-$4.00K
10-Q/A · filed 2014-03-10
2012-12-31$126.00
10-Q · filed 2014-10-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Functional Brands Inc. (MEHA)United States$0.001B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
MANNATECH INC (MTEX)United States$0.014B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87